XP13512 (GSK1838262)

· XenoPort, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XP13512 (GSK1838262), covering 2013-05-14 to 2013-05-14. Get the full timeline:

Most recent: Clinical Trial Update: XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome. [Phase 3]